HR 3743
117th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Health programs administration and funding
Medical research
Public-private cooperation
Research administration and funding
Tax-exempt organizations
Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act
Introduced: June 8, 2021
Introduced by:
Hudson, Richard
Republican
· North Carolina
See on congress.gov
Everywhere this bill has been
18 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 9, 2021
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 181.
Dec 8, 2021
Motion to reconsider laid on the table Agreed to without objection.
Dec 8, 2021
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 374 - 52 (Roll no. 424).
Dec 8, 2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 374 - 52 (Roll no. 424).
Dec 8, 2021
Considered as unfinished business. (consideration: CR H7542)
Nov 30, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Nov 30, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 3743.
Nov 30, 2021
Considered under suspension of the rules. (consideration: CR H6694-6695; text: CR H6694)
Nov 30, 2021
Mr. Pallone moved to suspend the rules and pass the bill.
Nov 30, 2021
Placed on the Union Calendar, Calendar No. 133.
Nov 30, 2021
Reported by the Committee on Energy and Commerce. H. Rept. 117-183.
Jul 21, 2021
Ordered to be Reported by Voice Vote.
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee by Voice Vote .
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Jun 9, 2021
Referred to the Subcommittee on Health.
Jun 8, 2021
Referred to the House Committee on Energy and Commerce.
Jun 8, 2021
Introduced in House
Votes taken on this bill
1
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Dec 9, 2021 | House · vote #424 | On Motion to Suspend the Rules and Pass | Passed | 374–52 | See who voted → |
Plain-English summary
Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act
This bill increases the amount of funds each fiscal year that the Food and Drug Administration (FDA) must transfer to the Reagan-Udall Foundation for the FDA and that the National Institutes of Health (NIH) must transfer to the Foundation for the NIH.
Specifically, it requires each agency to increase the amount transferred to its respective foundation (1) from a minimum of $500,000 to a minimum of $1,250,000, and (2) from a maximum of $1,250,000 to a maximum of $5,000,000.
What's happening now
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 181.
Committees of jurisdiction
2